NewsRoom Articles - Page 271 of 615

ThursdayJul 01, 2021 4:20 am

420 with CNW — Could Amazon’s Warming Up to Cannabis Signal a Federal Policy Change?

Since the emergence of the state-legal cannabis industry, there has been a pointed effort to keep “big business” out of the nascent sector. Most cannabis legislations have prioritized small businesses and equity applicants who were victims of cannabis prohibition in a bid to keep large corporations from coming in and taking over. But these established market players may just be what the industry needs, especially when it comes to federal legalization, and a recent announcement by e-commerce giant Amazon may spark the federal change cannabis players have been anxiously waiting for. At the start of the month, the American-based retailer…

WednesdayJun 30, 2021 4:20 pm

420 with CNW — Legislative Failure Prompts Mexican Supreme Court to Take Steps

The Supreme Court of Mexico is taking steps towards putting an end to cannabis prohibition on a national scale after the legislature failed to enact the change in policy. This comes almost three years after the same court declared that the prohibition of personal cannabis cultivation and possession was unconstitutional and ordered legislators to enact a change. While legislators did advance legalization measures after this, no bill was approved. In a press release issued earlier last week, #RegulationPorLaPas, a body that advocates for an end to marijuana prohibition, stated that the steps taken by the Supreme Court grew the responsibility…

WednesdayJun 30, 2021 2:16 pm

XPhyto Therapeutics Corp.’s (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT) Mescaline Program for Psychedelic Therapies is on Track

XPhyto Therapeutics Corp (OTCQB: XPHYF) announced its GMP mescaline synthesis program is “on schedule” The program, which started in early 2021, is slated for completion in late Q3 2021 The first initial production batches were completed successfully, marking a significant milestone for the program Mescaline will form a critical component in XPhyto’s psychedelic medicine program and work towards providing a foundation for its drug formulation and clinical validation work XPhyto Therapeutics (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT) recently announced that its Good Manufacturing Practices (“GMP”) mescaline synthesis program in North America is “on schedule” for completion in late Q3 2021…

WednesdayJun 30, 2021 1:55 pm

Pure Extracts Technologies Corp. (CSE: PULL) (OTC: PRXTF) (XFRA: A2QJAJ) Ships Initial Order of 0.5 Gram Vape Cartridges

Pure Extracts announced initial shipment of 0.5 gram vape cartridges to Alberta Gaming, Liquor & Cannabis CBD vape market has experienced strong growth in recent times, with one market research firm forecasting sector to be worth over $28bn by 2027 Pure Extracts has simultaneously sought to broaden its SKU’s within vape sector, commencing manufacture of larger, 1 gram FSO vape cartridge to better cater to changing customer demand patterns Pure Extracts Technologies (CSE: PULL) (OTC: PRXTF) (XFRA: A2QJAJ), a plant-based extraction company focused on the cannabis, hemp, functional mushrooms, and rapidly emerging psychedelic sector, announced that its whole owned subsidiary,…

WednesdayJun 30, 2021 11:28 am

Pac Roots Cannabis Corp. (CSE: PACR) (OTCQB: PACRF) (FSE: 4XM) Leading Out in Quest for Elusive Cannabis Prize

Cannabis space facing “critical moment” as consumers seek proven consistency Pac Roots partner, business model assists in commitment to deliver “predictable, reliable product” Pac Roots ideally positioned to preserve excellence of its elite strains while also introducing highest quality of new strains The cannabis industry has reached a crossroads of sorts, according to a recent “New York Times” article, as the substance has become increasingly mainstream. While welcome, the popularity of cannabis presents a challenge that companies such as Pac Roots Cannabis (CSE: PACR) (OTCQB: PACRF) (FSE: 4XM) are eager to meet. “The cannabis business, then, has arrived at a critical moment,”…

WednesdayJun 30, 2021 4:20 am

420 with CNW — Marijuana Cuts Migraine Pain, Headache by Almost Half, New Study Finds

A lot of people who have used cannabis regularly report that it has pain-relieving effects. But since cannabis has been illegal and intensely policed for such a long time, researchers have barely been able to conduct any research into its alleged health benefits. However, with more than 30 states legalizing cannabis in some form, the controversial drug is finally coming out from under the yoke of prohibition, and this has allowed scientists to take at a closer look at its medical capabilities. A recent study, which was published in the “Journal of Pain” has confirmed what many cannabis users have…

TuesdayJun 29, 2021 4:20 pm

420 with CNW — Researchers Develop Peptide That Allows Medical Cannabis to Alleviate Pain Without Inducing Side Effects

Researchers have created a peptide that can allow THC to combat pain without inducing the side effects it causes, as observed in mice. This could potentially bring relief to many individuals living with chronic pain and who have no access to medical marijuana. Data from the CDC shows that nearly 20% of grownups in the United States suffered from chronic pain in the year 2019. Opioids are the primary medication prescribed for severe pain management and are effective. However, they are easily addictive which has prompted many physicians to stop prescribing them, leaving patients who suffer from chronic pain with…

TuesdayJun 29, 2021 1:10 pm

Sugarmade, Inc. (SGMD) Is ‘One to Watch’

Sugarmade Inc. aims to expand its end-market access as a central player in the growing California cannabis delivery marketplace while developing its in-house cannabis production capacity to verticalize operations in the space The company has made key cannabis industry investments in NUG Avenue and BudCars On May 17, 2021, Sugarmade announced its entry into a definitive agreement for its acquisition of Lemon Glow Company Inc The Lemon Glow acquisition includes 640 acres of property, 32 of which have already been designated for outdoor cannabis cultivation California’s legal market hit $4.4 billion in sales in 2020, up from $2.8 billion in…

TuesdayJun 29, 2021 12:26 pm

Golden Triangle Ventures Inc. (GTVH) Finalizes Acquisition of Syndicate Bass Records, Announces Launch Event for Label

Acquisition enables GTVH, Lavish Entertainment to debut experimental bass music record label Hard Rock Live event spotlights artists that are releasing music on the Syndicate Bass Records label Company has built reputation for providing intricate, complex sounds; spotlighting artists from around the world Golden Triangle Ventures (OTC: GTVH) and its subsidiary Lavish Entertainment have completed an acquisition that enables the company to debut its own experimental bass music record label (https://cnw.fm/MwcaB). GTVH and its entertainment division signed off on the acquisition of Syndicate Bass Records LLC, a label collection curated by individuals who strongly believe in the impact of the…

TuesdayJun 29, 2021 9:33 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) (CSE: LXX) Is ‘One to Watch’

Lexaria Bioscience Corp. has disruptive proprietary technology protected by a broad international patent portfolio The company has been issued 19 patents in the U.S., European Union and other countries, with more than 50 patents pending around the world Lexaria’s DehydraTECH technology has a vast worldwide, multi-billion-dollar total addressable market, including multiple rapid-growth segments like cannabinoid and noncombustible nicotine delivery The company has licensed its fat-soluble active molecule delivery technology to multiple established companies for use in their products Lexaria completed an uplisting to Nasdaq Capital Markets and an $11 million financing in January 2021 Lexaria Bioscience (NASDAQ: LEXX) (CSE: LXX)…